University of Minnesota
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).
University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.
University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.
Top-decile sponsor footprint
University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
966 total, page 9 of 20
Signatures of N-Ac for Non-Suicidal Self-Injury in Adolescents
NCT04005053
Fecal Transplant for Ulcerative Colitis
NCT03948919
Adaptive Preventive Intervention for College Alcohol Use
NCT03930524
Validation of Bladder Health Instrument for Evaluation in Women
NCT04016298
Mindful Movement for Physical Activity and Wellbeing in Older Adults- A Hybrid Effectiveness-Implementation Study
NCT03929393
Clinical Impact of Red Cell Storage Age
NCT05482737
Maximizing the Impact of Neuroplasticity Using Transcranial Electrical Stimulation Study 2
NCT03896438
PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant
NCT03763643
Assessing a New Jaw Support Device During Third Molar Extractions
NCT03975920
Cf-DNA Assay During Treatment of Acute Rejection
NCT04019353
Positive Affect Treatment (PAT) to Target Reward Mechanisms in Anorexia Nervosa
NCT04007900
Impact of Brief Motivational Interviewing on Periodontal Clinical Outcomes: a 3-year Post-trial Follow-up
NCT05336396
Scaling and Root Planing (SRP) With and Without Minocycline HCl Microspheres, 1 mg
NCT03762915
The MOMENTUM Study (Monitoring Maternal Emergency Navigation and Triage on Mfangano
NCT03942536
Adoptive Transfer of Haploidentical NK Cells and N-803
NCT03899480
Green Exercise for Cancer - Creating Opportunities for Survivors
NCT03852758
Utilizing Senior Companions to Enhance Dementia Care
NCT03667924
Sunfiber and the Microbiota
NCT03722862
Laryngeal Vibration for Spasmodic Dysphonia
NCT03746509
Maximizing the Impact of Neuroplasticity Using Transcranial Electrical Stimulation Study 1
NCT03896425
Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for Psychosis
NCT02085421
Treating Smokers With Mental Illness
NCT03822416
Concurrent Aerobic Exercise and Virtual Reality Cognitive Training
NCT02963415
Mindful Breathing and tDCS for Depression
NCT03897699
Exparel PK and Breast Milk Excretion
NCT03526419
Piloting "Positive Peer Journaling" a Journaling Practice to Support Recovery From Addiction
NCT03903159
Pregnancy Weight Tracking Pilot Project
NCT03652766
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
NCT03343093
Mentorship Program for Individuals With Autism Spectrum Disorder (ASD)
NCT05300295
Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia
NCT03718234
CHAT at HOME Pilot Study
NCT03661918
Ginger and Gut Microbiome (GINGER)
NCT03268655
Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back Pain
NCT03581123
MRS to Determine Neuroinflammation and Oxidative Stress in MPS I
NCT03576729
Gum Acacia and Blood Glucose
NCT03716479
Assessing the Effects Of Treadmill On LPA, Sitting Time, and Cardiovascular Risk
NCT03236597
Stress Reactivity as a Determinant in Co-occurring Alcohol Use and Anxiety Disorder: Diagnosis and Alcohol Use Outcomes
NCT03056872
Ultrasound Treatment of Rheumatoid Arthritis
NCT03690466
Telestroke for Comprehensive Stroke Care in Acute Stroke Ready Hospitals
NCT03672890
Telestroke for Comprehensive Transient Ischemic Attack Care in Acute Stroke Ready Hospitals
NCT03724110
Youth Epilepsy and Successful Self-Management Intervention
NCT03639233
Graded Motor Imagery for Women at Risk for Developing Type I CRPS Following Closed Treatment of Distal Radius Fractures
NCT02957240
Role of CGMS Usage in Predicting Risk for Hypoglycemia
NCT03481530
Brief Motivational Interviewing (BMI)
NCT03571958
The Impact of Oxytocin on the Neurobiology of Anorexia Nervosa
NCT03414112
Liposome Bupivacaine Interscalene Total Shoulder
NCT03587636
Occurrence of Post-op Pain Following Gentlewave
NCT03635515
Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System
NCT03889093
Assessing Leg Control in People With Chronic Stroke
NCT03271463
Adipokines Effect in Myometrial Contractility
NCT03505541
What is open in the University of Minnesota pipeline
180 recruiting of 966 indexed (19% open); 671 completed (69%).
Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).
Top condition: Obesity (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Minnesota: open-pipeline peers nationwide
Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 966 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Alabama at Birmingham · 19% recruiting · 1,160 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Minnesota page
966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.
- 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Minnesota pipeline card: 966 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.